AzTrials
AzTrials

Whole Body VibrationNCT06058169

Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)

A study testing Sub Acute Whole Body Vibration Training in people with Whole Body Vibration and Osteo Arthritis Knee, run by Augusta University at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The purpose of this proposal is to understand how the Vibrant Health Ultimate whole-body vibration (WBV) machine affects pain and inflammation in older adults. The investigators' hypothesize that sub-acute (12 weeks) WBV will lead to improvement in the level of knee pain and improve vascular function via a decrease in… Read more about this study

Who is it for?
Ages 40 to 75 years
Conditions the study is for
Whole Body Vibration, Osteo Arthritis Knee
What is being tested?
Sub Acute Whole Body Vibration Training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
25 Apr 2025to 1 Nov 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Symptomatic Osteoarthritic knee pain for at least 6 months.
  • Mean and women
  • Ages 40-75 years old

Who cannot join

  • <40 years old or >75 years old
  • History of balance issues
  • History of falls
  • Epilepsy
  • Pregnancy
  • The use of whole-body vibration in the past 6 months
  • Previous knee surgery within last 3 years
  • Unable to stand for at least 20 minutes (for whole body vibration training)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology

    Augusta, Georgia, 30912

Other trials in United States

About this study

Official title: Pilot Investigation on the Effects of Sub Acute (12 Week) Home Base Whole-body Vibration Training in Osteoarthritis.

The purpose of this proposal is to understand how the Vibrant Health Ultimate whole-body vibration (WBV) machine affects pain and inflammation in older adults. The investigators' hypothesize that sub-acute (12 weeks) WBV will lead to improvement in the level of knee pain and improve vascular function via a decrease in systemic inflammation.

Read the detailed description

Knee osteoarthritis (KO) is a leading cause of disability and medical cost. Whole body vibration (WBV) has emerged as an exercise alternative that may be more tolerable than traditional forms of exercise, such as treadmill walking/running or cycling. Similar to traditional exercise, research supports that WBV can be very beneficial for your health. In fact, a single bout of WBV increases circulating concentrations of inflammatory markers. WBV is safe and effective, WBV training has been conducted in obesity, elderly, patients with diabetes, patients with lung disease, as well as patients with knee osteoarthritis.

Being tested
Sub Acute Whole Body Vibration Training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sub Acute Whole Body Vibration TrainingDevice

    Participants will be given a personal vibration plate (equipped with stabilizing bars) to take home for training which will last for up 12 weeks. For this test the participant will be asked to stand on a vibration plate for up to 20 minutes. Participants will be instructed to remove any footwear and stand mid-center on the platform in a standing position with feet shoulder width apart. The participant will be asked to step on and off of the vibration plate. During the first four weeks, participants will be asked to complete 5-10 minutes of WBV per day, at least 4-5 days per week. At least 24 hours will be recommended in between sessions during weeks 1-4. Beginning at week 5, participants will be asked to increase WBV time to up to 15 minutes and/or reduce the duration of rest. Beginning at week 9, based on how the participant feels, the study team may adjust the WBV time/duration up to 20 minutes per session, 4-5 days per week.

Study groups in NCT06058169
Study groupRoleWhat they receive
Whole Body Training (12 week)ExperimentalNot described
Receives: Device: Sub Acute Whole Body Vibration Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Pressure Threshold assessed using the Jtech Medical Echo Algometer

    change from baseline pain pressure threshold at 12 weeks. Pain Pressure Threshold (PPT) will be assessed using the Jtech Medical Echo Algometer. PPT is used to measure deep muscular tissue sensitivity. The test determines the amount of pressure over a given area in which a steadily increasing non-painful pressure stimulus turns into an uncomfortable or painful pressure sensation. The subject will lie supine. An investigator will assess PPT at the following sites: a) 2 cm below the medial edge of the patella and b) 2 cm below the lateral edge of the patella. Using the 1 cm2 probe, the investigator will place it perpendicular to each site and apply pressure at a rate of 0.5 kg/cm2/s. Each trial will stop when the subject reports pain. The investigator will take 3 trials at each site; the average of the 3 trials, recorded in kg/cm2, will be used for statistical analysis.

    Measured: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

Secondary outcomes (2)
  1. Change in Pulse Wave Velocity (PWV)

    Change from baseline PWV at 12 weeks. Measured by Shygmocor Xcel in m/s.

    Measured: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

  2. Change in IL-6

    change from baseline concentrations of Interleukin 6 (IL-6) obtained via blood draw at 12 weeks.

    Measured: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2023
  2. Study start25 Apr 2025
  3. Primary completion1 Oct 2026
  4. Study completion1 Nov 2026 (estimated)

Why it stopped: funding issues

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06058169
Sponsor's protocol ID
2054289
Status last verified
May 2026
First submitted
22 Sep 2023
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Sub Acute Whole Body Vibration Training in people with Whole Body Vibration and Osteo Arthritis Knee, run by Augusta University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Pressure Threshold assessed using the Jtech Medical Echo Algometer (time frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in